Additional file 2: of The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype

Validation of binding sites by peak height in independent samples.ZR-75-1 cells were plated, treated, ChIP and subjected to RT-qPCR as described in materials and methods. (XLS 1611 kb)